SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001372514-23-000117
Filing Date
2023-08-08
Accepted
2023-08-08 07:13:35
Documents
60
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kprx-20230630.htm   iXBRL 10-Q 873398
2 EX-31.1 kprx-20230630xexx311.htm EX-31.1 7433
3 EX-31.2 kprx-20230630xexx312.htm EX-31.2 7441
4 EX-32.1 kprx-20230630xexx321.htm EX-32.1 3840
5 EX-32.2 kprx-20230630xexx322.htm EX-32.2 3837
  Complete submission text file 0001372514-23-000117.txt   5372195

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kprx-20230630.xsd EX-101.SCH 43163
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kprx-20230630_cal.xml EX-101.CAL 49898
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kprx-20230630_def.xml EX-101.DEF 237287
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kprx-20230630_lab.xml EX-101.LAB 652485
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kprx-20230630_pre.xml EX-101.PRE 402695
54 EXTRACTED XBRL INSTANCE DOCUMENT kprx-20230630_htm.xml XML 555297
Mailing Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024
Business Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024 781-788-8869
KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36672 | Film No.: 231149292
SIC: 2834 Pharmaceutical Preparations